Novel therapy for liver cancer

Direct intraarterial injection of an ATP production inhibitor is an effective inhibitor of liver cancer in rabbits.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Patients with liver cancer that cannot be treated with surgical resection or transplantation have few other therapeutic options, and are in need of novel interventions. In 15 July Cancer Research, Jean-Francois Geschwind and colleagues at The Johns Hopkins University School of Medicine, show that direct intraarterial injection of an ATP production inhibitor is an effective inhibitor of liver cancer in rabbits and may be a treatment alternative in humans (Cancer Res 2002, 62:3909-3913).

Geschwind et al. tested intraarterial delivery of 3-bromopyruvate (3-BrPA — a potent inhibitor of cell ATP production), directly to the site of rabbit liver tumors. They observed that this treatment induced a rapid and effective destruction of most cancer cells within the liver. In addition, systemic delivery of 3-BrPA suppressed 'metastatic' tumors that arose in the lungs. Few side effects were associated with either of these treatment regimens.

These results suggest that intraarterial delivery of anti-tumor drugs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series